Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Jum Suk Ko"'
Autor:
Moonki Jung, Kyeongmin Byeon, Ki‐Woon Kang, Wang‐Soo Lee, Sang Wook Kim, Yae Min Park, You Mi Hwang, Sung Ho Lee, Eun‐Sun Jin, Seung‐Young Roh, Jin Seok Kim, Jinhee Ahn, So‐Ryoung Lee, Eue‐Keun Choi, Min‐Soo Ahn, Eun Mi Lee, Hwan‐Cheol Park, Ki Hong Lee, Min Kim, Joon Hyouk Choi, Jum Suk Ko, Jin Bae Kim, Changsoo Kim, Gregory Y. H. Lip, Seung Yong Shin, the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF) Investigators
Publikováno v:
Journal of Arrhythmia, Vol 39, Iss 3, Pp 376-387 (2023)
Abstract Background The balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear in atrial fibrillation (AF) at non‐gender CHA2DS2‐VASc scores 0–1. A net clinical benefit (NCB)
Externí odkaz:
https://doaj.org/article/e4e63b16fc994441982a97b47aa09b2e
Autor:
Jeong Gwan Cho MD, PhD, Ki Hong Lee MD, PhD, Yoo Ri Kim MD, PhD, Sunah Kim RN, CRC, CRA, Jisoo Gwak RN, CRC, CRA, Eunbit Cho MLS, CRC, CRA, Yourim Sin RN, CRC, CRA, Seung Yong Shin MD, PhD, Hyung Wook Park MD, PhD, Jum Suk Ko MD, PhD, Nam Ho Kim MD, PhD, Yae Min Park MD, PhD, Jung Myung Lee MD, PhD, Nam Sik Yoon MD, PhD, Sung Soo Kim MD, PhD, Jun Hyung Kim MD, PhD, Dong Min Kim MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Anticoagulation with warfarin in Asian patients with atrial fibrillation (AF) often has been decreased as an international normalized ratio (INR) of prothrombin time 1.6-2.6 due to fear of bleeding, although universal criteria recommend an INR of 2.0
Externí odkaz:
https://doaj.org/article/e9a27eb9005844d282d14ef4be786989
Autor:
Jae Young Cho, Seung‐Yul Lee, Kyeong Ho Yun, Byeong‐Keuk Kim, Sung‐Jin Hong, Jum Suk Ko, Sang Jae Rhee, Seok Kyu Oh, Dong‐Ho Shin, Chul‐Min Ahn, Jung‐Sun Kim, Young‐Guk Ko, Donghoon Choi, Myeong‐Ki Hong, Yangsoo Jang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 7 (2021)
Background There is a lack of data on factors that are related to clinically relevant bleeding after ticagrelor treatment. We investigated the clinical and procedural factors related to major bleeding in patients with acute coronary syndrome treated
Externí odkaz:
https://doaj.org/article/17714e6a17a64363966b9acca7c2a73c
Autor:
Shinjeong Song, Jum-Suk Ko, Hye Ah Lee, Eue-Keun Choi, Myung-Jin Cha, Tae-Hoon Kim, Jin-Kyu Park, Jung-Myung Lee, Ki-Woon Kang, Jaemin Shim, Jae-Sun Uhm, Jun Kim, Changsoo Kim, Jin-Bae Kim, Hyung Wook Park, Boyoung Joung, Junbeom Park
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundAtrial fibrillation (AF) is treated by heart rate (HR) control. However, the optimal HR target in AF patients with heart failure (HF) remains unclear. To evaluate the clinical implication of the resting HR in AF patients with HF accompanied
Externí odkaz:
https://doaj.org/article/175bfcef23f54193920b3a1e9081e2fe
Autor:
Jum Suk Ko1, Hyung Ki Jeong1 jhk30334@hanmail.net
Publikováno v:
Chonnam Medical Journal. Sep2021, Vol. 57 Issue 3, p191-196. 6p.
Autor:
Nam Ho Kim1 nemor@daum.net, Jum Suk Ko1
Publikováno v:
Chonnam Medical Journal. Jan2021, Vol. 57 Issue 1, p1-6. 6p.
Autor:
Moonki, Jung, Kyeongmin, Byeon, Ki-Woon, Kang, Yae Min, Park, You Mi, Hwang, Sung Ho, Lee, Eun-Sun, Jin, Seung-Young, Roh, Jin Seok, Kim, Jinhee, Ahn, So-Ryoung, Lee, Eue-Keun, Choi, Min-Soo, Ahn, Eun Mi, Lee, Hwan-Cheol, Park, Ki Hong, Lee, Min, Kim, Joon Hyouk, Choi, Jum Suk, Ko, Jin Bae, Kim, Changsoo, Kim, Gregory Y H, Lip, Seung Yong, Shin
Publikováno v:
Yonsei medical journal. 63(10)
Atrial fibrillation (AF) patients with low to intermediate risk, defined as non-gender CHAThis multi-center cohort study retrospectively analyzed AF patients with non-gender CHAOverall, 2694 patients [56.3±9.5 years; female, 726 (26.9%)] were follow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3fbfadfa503f8bf1a8ad169f1e7356ef
https://pubmed.ncbi.nlm.nih.gov/36168241
https://pubmed.ncbi.nlm.nih.gov/36168241
Publikováno v:
Chonnam Medical Journal. 59:103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1847955eea3c5e43e027862cb4d04bc0
https://doi.org/10.4068/cmj.2023.59.1.103
https://doi.org/10.4068/cmj.2023.59.1.103
Autor:
Shinjeong Song, Jum-Suk Ko, Hye Ah Lee, Eue-Keun Choi, Myung-Jin Cha, Tae-Hoon Kim, Jin-Kyu Park, Jung-Myung Lee, Ki-Woon Kang, Jaemin Shim, Jae-Sun Uhm, Jun Kim, Changsoo Kim, Jin-Bae Kim, Hyung Wook Park, Boyoung Joung, Junbeom Park
Publikováno v:
Frontiers in cardiovascular medicine. 9
BackgroundAtrial fibrillation (AF) is treated by heart rate (HR) control. However, the optimal HR target in AF patients with heart failure (HF) remains unclear. To evaluate the clinical implication of the resting HR in AF patients with HF accompanied
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6651effea62393820174fcd169e8506a
https://pubmed.ncbi.nlm.nih.gov/35391851
https://pubmed.ncbi.nlm.nih.gov/35391851
Autor:
Young Joon Hong, Myung Ho Jeong, Yun Ha Choi, Eun Hye Ma, Jum Suk Ko, Min Goo Lee, Keun Ho Park, Doo Sun Sim, Nam Sik Yoon, Hyun Ju Youn, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang
Publikováno v:
In International Journal of Cardiology 2010 144(3):367-372